UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

Annals of oncology, 2014-10, Vol.25 (10), p.1871-1888

2014

Volltextzugriff (PDF)

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

Breast (Edinburgh), 2014-10, Vol.23 (5), p.489-502

2014

Volltextzugriff (PDF)

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

Annals of oncology, 2014-10, Vol.25 (10), p.1979-1987

2014

Volltextzugriff (PDF)

1st International consensus guidelines for advanced breast cancer (ABC 1)

Breast (Edinburgh), 2012-06, Vol.21 (3), p.242-252

2012

Volltextzugriff (PDF)

Intérêt des classifications moléculaires pour prédire la rechute locale et la diffusion métastatique des cancers du sein

Cancer radiothérapie, 2008-11, Vol.12 (6), p.577-583

2008

Volltextzugriff (PDF)

A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study

Annals of oncology, 2014-09, Vol.25 (9), p.1775-1782

2014

Volltextzugriff (PDF)

1968 Routine practice use of Oncotype Dx assay in French breast cancer patients

European journal of cancer (1990), 2015-09, Vol.51, p.S323-S323

2015

Volltextzugriff (PDF)

Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer

Brazilian journal of medical and biological research, 2015-01, Vol.48 (1), p.13-24

2015

Volltextzugriff (PDF)

Radiotherapy for invasive breast cancer: Guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence

Critical reviews in oncology/hematology, 2011-08, Vol.79 (2), p.91-102

2011

Volltextzugriff (PDF)

PONDx: a prospective multicenter French study of the 21-gene assays: impact on treatment selection in patients with high-risk breast cancer

Breast (Edinburgh), 2017-03, Vol.32, p.S61-S61

2017

Volltextzugriff (PDF)

1956 Safety and tolerability of subcutaneous trastuzumab for HER2-positive early breast cancer in patients with lower body weight and in Asian patients: SafeHer Phase III study subgroup analyses

European journal of cancer (1990), 2015-09, Vol.51, p.S318-S318

2015

Volltextzugriff (PDF)

Modification du métabolisme tumoral au cours du traitement: suivi de la réponse thérapeutique par tomographie par émission de positons : Métabolisme et cancer

Oncologie (Paris, France), 2013, Vol.15 (9), p.448-453

2013

Volltextzugriff (PDF)

Triple negative breast cancer: Proposals for a pragmatic definition and implications for patient management and trial design

Breast (Edinburgh), 2012-02, Vol.21 (1), p.20-26

2012

Volltextzugriff (PDF)

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

European journal of cancer (1990), 2011-11, Vol.47 (16), p.2396-2402

2011

Volltextzugriff (PDF)

Cancers du Sein Métastatique : Réflexions stratégiques sur la prise en charge de la chimiothérapie de 1ere ligne

Oncologie (Paris, France), 2006, Vol.8 (1), p.36-50

2006

Volltextzugriff (PDF)

445 PrefHer: a Clinical Trial to Evaluate Patient Preference for Trastuzumab Administered Subcutaneously or Intravenously in Patients with HER2-positive Early Breast Cancer

European journal of cancer (1990), 2012-03, Vol.48, p.S176-S176

2012

Volltextzugriff (PDF)

PMD51 Cost-Effectiveness of a Predictive Test of the Benefit of Chemotherapy

Value in health, 2012-11, Vol.15 (7), p.A354-A354

2012

Volltextzugriff (PDF)

P103 Subcutaneous trastuzumab plus chemotherapy for early breast cancer: interim safety from SafeHer

Breast (Edinburgh), 2015-03, Vol.24, p.S60-S61

2015

Volltextzugriff (PDF)

Prevalence and Treatment of Oropharyngeal Candidiasis in Cancer Patients: The CANDIDOSCOPE Study

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S130-S130

2009

Volltextzugriff (PDF)

Chimiothérapie des tumeurs trophoblastiques gestationnelles à haut risque : Actualités sur les tumeurs de l'ovaire et les maladies trophoblastiques gestationnelles

Oncologie (Paris, France), 2014, Vol.16 (6), p.291-299

2014

Volltextzugriff (PDF)

International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)–MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer

Breast (Edinburgh), 2013-06, Vol.22 (3), p.203-210

2013

Volltextzugriff (PDF)

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

European journal of cancer (1990), 2017-09, Vol.82, p.237-246

2017

Volltextzugriff (PDF)

The 21-Gene Assay In The Decision Impact Assessment of ER+, HER2- Breast Cancer: A French Real Life Prospective Study

Value in health, 2016-11, Vol.19 (7), p.A685-A685

2016

Volltextzugriff (PDF)

59 Indications of adjuvant chemotherapy for breast cancer according to local guidelines, recursive partition and Adjuvant! Online: how to improve patient management?

European journal of cancer supplements, 2010, Vol.8 (3), p.76-76

2010

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(59)

Sprache

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(24)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(15)
Oncology
(14)
Female
(12)
Sciences Biologiques Et Medicales
(12)
Sciences Medicales
(12)
Tumeurs
(12)
Experiment
(10)
High Energy Physics - Experiment
(10)
Particle Physics
(10)
Physics
(10)
Breast Cancer
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Antineoplastic Agents
(6)
Breast Neoplasms - Drug Therapy
(6)
Breast Neoplasms - Pathology
(6)
Adult
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

1st International consensus guidelines for advanced breast cancer (ABC 1)

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

Intérêt des classifications moléculaires pour prédire la rechute locale et la diffusion métastatique des cancers du sein

A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study

1968 Routine practice use of Oncotype Dx assay in French breast cancer patients

Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer

Radiotherapy for invasive breast cancer: Guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence

PONDx: a prospective multicenter French study of the 21-gene assays: impact on treatment selection in patients with high-risk breast cancer

1956 Safety and tolerability of subcutaneous trastuzumab for HER2-positive early breast cancer in patients with lower body weight and in Asian patients: SafeHer Phase III study subgroup analyses

Modification du métabolisme tumoral au cours du traitement: suivi de la réponse thérapeutique par tomographie par émission de positons : Métabolisme et cancer

Triple negative breast cancer: Proposals for a pragmatic definition and implications for patient management and trial design

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

Cancers du Sein Métastatique : Réflexions stratégiques sur la prise en charge de la chimiothérapie de 1ere ligne

445 PrefHer: a Clinical Trial to Evaluate Patient Preference for Trastuzumab Administered Subcutaneously or Intravenously in Patients with HER2-positive Early Breast Cancer

PMD51 Cost-Effectiveness of a Predictive Test of the Benefit of Chemotherapy

P103 Subcutaneous trastuzumab plus chemotherapy for early breast cancer: interim safety from SafeHer

Prevalence and Treatment of Oropharyngeal Candidiasis in Cancer Patients: The CANDIDOSCOPE Study

Chimiothérapie des tumeurs trophoblastiques gestationnelles à haut risque : Actualités sur les tumeurs de l'ovaire et les maladies trophoblastiques gestationnelles

International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)–MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

The 21-Gene Assay In The Decision Impact Assessment of ER+, HER2- Breast Cancer: A French Real Life Prospective Study

59 Indications of adjuvant chemotherapy for breast cancer according to local guidelines, recursive partition and Adjuvant! Online: how to improve patient management?

Aktive Filter

Suchergebnisse filtern